Terms: = Leukemia AND ZNF331, Q9NQX6, 55422, ENSG00000130844, ZNF361, RITA, ZNF463 AND Treatment
4 results:
1. Nucleolar phosphoprotein modifications as a marker of apoptosis induced by rita treatment.
Wolfová K; Otevřelová P; Holoubek A; Brodská B
Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119501. PubMed ID: 37276927
[TBL] [Abstract] [Full Text] [Related]
2. rita induces apoptosis in p53-null K562 leukemia cells by inhibiting STAT5, Akt, and NF-κB signaling pathways.
Mobaraki RN; Karimi M; Alikarami F; Farhadi E; Amini A; Bashash D; Paridar M; Kokhaei P; Rezvani MR; Kazemi A; Safa M
Anticancer Drugs; 2018 Oct; 29(9):847-853. PubMed ID: 30157040
[TBL] [Abstract] [Full Text] [Related]
3. rita enhances chemosensivity of pre-B ALL cells to doxorubicin by inducing p53-dependent apoptosis.
Kazemi A; Safa M; Shahbazi A
Hematology; 2011 Jul; 16(4):225-31. PubMed ID: 21756539
[TBL] [Abstract] [Full Text] [Related]
4. Mutated and non-mutated TP53 as targets in the treatment of leukaemia.
Nahi H; Selivanova G; Lehmann S; Möllgård L; Bengtzen S; Concha H; Svensson A; Wiman KG; Merup M; Paul C
Br J Haematol; 2008 May; 141(4):445-53. PubMed ID: 18341636
[TBL] [Abstract] [Full Text] [Related]
